Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Awaiting development
Guidance and quality standards
Awaiting development
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Filter by title or keyword
Filter
Area of interest
Area of interest
COVID-19 (9)
Type
Type
Guidance (315)
Quality standard (31)
Guidance programme
Guidance programme
Diagnostics guidance (2)
Health technology evaluations (1)
Highly specialised technologies guidance (1)
Interventional procedures guidance (15)
Medical technologies guidance (7)
Technology appraisal guidance (289)
Apply filters
Showing 1 to 50 of 346
Guidance and quality standards awaiting development
Title
Type
Phrenic nerve pacing for ventilator-dependent high cervical spinal cord injury
Interventional procedures guidance
Phrenic nerve pacing for congenital central hypoventilation syndrome
Interventional procedures guidance
Caval valve implantation for tricuspid regurgitation
Interventional procedures guidance
Single-step scaffold insertion for repairing symptomatic chondral knee defects
Interventional procedures guidance
Selpercatinib for treating advanced thyroid cancer with RET alterations (MA review of TA742) [ID6288]
Technology appraisal guidance
Endoscopic bipolar radiofrequency ablation for malignant biliary obstruction
Interventional procedures guidance
Unilateral MRI-guided focused ultrasound thalamotomy for moderate-to-severe tremor in Parkinson's disease
Interventional procedures guidance
MRI guided focused ultrasound subthalamotomy in parkinson's disease
Interventional procedures guidance
Transperineal laser ablation (TPLA) for treating lower urinary tract symptoms of benign prostatic hyperplasia using a ultra-micro invasive approach.
Interventional procedures guidance
Electrically stimulated intravesical therapy for Interstitial Cystitis
Interventional procedures guidance
Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis
Interventional procedures guidance
Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention
Interventional procedures guidance
Laparoscopic insertion of a non-active implant for gastro-oesophageal reflux disease
Interventional procedures guidance
Pulsed Field Ablation (PFA) for atrial fibrillation
Interventional procedures guidance
Targeted Muscle Reinnervation for refractory pain after limb amputation
Interventional procedures guidance
Masitinib with riluzole for treating amyotrophic lateral sclerosis TS ID 10728
Technology appraisal guidance
Pembrolizumab with neoadjuvant chemotherapy and adjuvant endocrine therapy for treating ER-positive, HER2-negative early breast cancer [ID3993]
Technology appraisal guidance
Bupivacaine–meloxicam for treating postoperative pain [ID2728]
Technology appraisal guidance
Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833]
Technology appraisal guidance
Acne
Quality standard
Baloxavir marboxil for treating influenza in people at high risk of complications [ID3794]
Technology appraisal guidance
Lisocabtagene maraleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma after 1 systemic treatment [ID3869]
Technology appraisal guidance
Nicardipine (Nicaplant) for aneurysmal subarachnoid haemorrhage patients undergoing aneurysm clipping TS ID 10593
Technology appraisal guidance
Liposomal cytarabine–daunorubicin for treating relapsed or refractory acute myeloid leukaemia in people aged 1 to 21 years [ID4017]
Technology appraisal guidance
Zamtocabtagene autoleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more therapies TS ID 10765
Technology appraisal guidance
REGN5458 for treating relapsed or refractory multiple myeloma TS ID 10443
Technology appraisal guidance
Cenobamate for adjunctive treatment of primary generalised tonic-clonic seizures in epilepsy TS ID 10214
Technology appraisal guidance
Estetrol for treating vasomotor symptoms associated with the menopause in people aged 40 to 65 ID4037
Technology appraisal guidance
Idecabtagene vicleucel for treating relapsed or refractory multiple myeloma after 2 to 4 therapies TS ID 10330
Technology appraisal guidance
Palbociclib for treating high-risk early breast cancer after neoadjuvant chemotherapy [ID3846]
Technology appraisal guidance
Sotagliflozin for treating type 2 diabetes [ID1657]
Technology appraisal guidance
Baloxavir marboxil for influenza prophylaxis in people aged 12 and over [ID3793]
Technology appraisal guidance
Rivoceranib for treating unresectable or advanced gastric or gastro-oesophageal junction cancer after 2 or more therapies [ID3819]
Technology appraisal guidance
Supporting independent living and preventing isolation in adults of working age with social care needs
Quality standard
Adults with lifelong or very severe hearing or visual impairment: health, well-being and social care
Quality standard
Plinabulin with docetaxel for previously treated advanced non-small-cell lung cancer [ID3895]
Technology appraisal guidance
Vosoritide for treating achondroplasia in children and young people under 18 years [ID3807]
Technology appraisal guidance
Durvalumab with tremelimumab and chemotherapy for treating unresectable or advanced urothelial cancer [ID3855]
Technology appraisal guidance
Advocacy services for adults with health and social care needs
Quality standard
Children and young people with disabilities and severe complex needs: integrated health and social care support
Quality standard
Timrepigene emparvovec for treating choroideremia [ID3916]
Technology appraisal guidance
Omecamtiv mecarbil for treating chronic heart failure with reduced ejection fraction [ID3912 ]
Technology appraisal guidance
Inolimomab (Leukotac) for acute Graft versus host disease (aGvHD) after Allo-HSCT [ID3923]
Technology appraisal guidance
Mavorixafor for treating WHIM syndrome ID3946
Technology appraisal guidance
Safe prescribing and withdrawal management of prescribed drugs associated with dependence and withdrawal
Quality standard
Safeguarding adults in care homes
Quality standard
Istradefylline with levodopa for treating motor fluctuations in Parkinson's disease [ID3868]
Technology appraisal guidance
Ixazomib citrate for maintenance treatment of untreated multiple myeloma after autologous stem cell transplant [ID1517]
Technology appraisal guidance
Benralizumab for previously treated severe nasal polyps [ID1659]
Technology appraisal guidance
Sparsentan for treating focal segmental glomerulosclerosis in people 8 years and over [ID3955]
Technology appraisal guidance
Current page
1
2
3
…
7
Page
1
of
7
Next page
Results per page
10
25
50
All
Back to top